SCHEMBL9638465

SCHEMBL9638465

Cc1cc(N(C)C)cc(C)c1N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
TSHR P16473 6/20 0.52
TDP1 Q9NUW8 4/20 0.52
CYP3A4 P08684 3/20 0.52
TP53 P04637 2/20 0.52
POLB P06746 1/20 0.44
ALOX15 P16050 2/20 0.42
MAPK1 P28482 2/20 0.42
APAF1 O14727 1/20 0.38
HSD17B10 Q99714 2/20 0.38
MAPT P10636 1/20 0.38
S100B P04271 1/20 0.35
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
NSD2 O96028 1/20 0.32
CASP3 P42574 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11325204 0.82 ALDH1A1 (0.52) ALDH1A1TSHRTDP1CYP3A4TP53
SCHEMBL17928551 0.80 ALDH1A1 (0.46) ALDH1A1TSHRTDP1CYP3A4TP53
SCHEMBL21543263 0.80 ALDH1A1 (0.34) ALDH1A1TSHRTDP1CYP3A4TP53
SCHEMBL19435865 0.77 ALDH1A1 (0.67) ALDH1A1TSHRTDP1CYP3A4TP53
SCHEMBL13990206 0.77 TSHR (0.48) ALDH1A1TSHRTDP1CYP3A4TP53
SCHEMBL7698213 0.77 TSHR (0.48) ALDH1A1TSHRTDP1CYP3A4TP53
SCHEMBL19432167 0.74 ALDH1A1 (0.70) ALDH1A1TSHRTDP1CYP3A4TP53
SCHEMBL16359030 0.72 TSHR (0.44) ALDH1A1TSHRTDP1CYP3A4TP53
SCHEMBL14037004 0.72 TSHR (0.44) ALDH1A1TSHRTDP1CYP3A4TP53
SCHEMBL33872 0.72 S100B (0.61) ALDH1A1TSHRTDP1CYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250186979-A1 CATALYST SYSTEM AND PROCESS FOR THE PREPARATION OF ALPHA OLEFINS AND ALPHA OLEFIN-CONTAINING PRODUCTS FROM LONG-CHAIN PARAFFINS PANNON EGYETEM (HU) 2025-06-12 US disclosed
CN-109641852-B Sulfonamides as GPR 40-and GPR 120-agonists 东佩制药股份公司 2022-08-26 CN disclosed
EP-3497085-B1 SULFONAMIDES AS GPR40- AND GPR120-AGONISTS DOMPE FARM SPA (IT) 2020-07-22 EP disclosed
US-20190169142-A1 SULFONAMIDES AS GPR40- AND GPR120-AGONISTS DOMPÉ FARMACEUTICI S.P.A. (IT) 2019-06-06 US disclosed
EP-3281937-A1 SULFONAMIDES AS GPR40- AND GPR120-AGONISTS Dompé farmaceutici S.p.A. (IT) 2018-02-14 EP disclosed
US-5153218-A N,N',N'-trisubstituted-bis-amino-3-methylene-2,4(3H,5H)-furandione inhibitors of acyl-CoA:cholesterol-acyl transferase AMERICAN HOME PRODUCTS CORPORATION (US) 1992-10-06 US disclosed
US-4008999-A N,N-dialkylamino diphenylamines for dyeing keratinic fibers SOCIETE ANONYME DITE: L'OREAL (FR) 1977-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250186979-A1 CATALYST SYSTEM AND PROCESS FOR THE PREPARATION OF ALPHA OLEFINS AND ALPHA OLEFIN-CONTAINING PRODUCTS FROM LONG-CHAIN PARAFFINS MAX, ECH1, PCNA ALDH1A1 1569/4885TSHR 4509/4885TDP1 3431/4885
US-20190169142-A1 SULFONAMIDES AS GPR40- AND GPR120-AGONISTS GPR119, GPR88, GPR84 ALDH1A1 3932/4885TSHR 267/4885TDP1 4734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.